About Me

- Name: William Murrell Dubai Sports Doctor
- Location: Dubai, Middle-East, United Arab Emirates
Consultant Orthopaedic Sports Medicine, Dubai Bone and Joint Center, Dubai UAE, American Board Certified Orthopaedic Sports Medicine, Member of American Orthopaedic Society Sports Medicine, Fellow American Academy of Orthopaedic Surgeons, Member American Orthopaedic Association, Member International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine, Member Surgeons Circle-Orthopaedics Overseas.
Previous Posts
- Zimmer introduces Chondrofix Osteochondral Allograft
- PRP an unproven option, agree forum experts
- JBJS | Platelet-Rich Plasma Differs According to P...
- JBJS | Efficacy of Autologous Platelet-Rich Plasma...
- Platelet rich plasma returned most athletes to pla...
- Dubai Duty Free Tennis Classic-DBAJ Official Healt...
- National Conference on Sports Medcine and Rehabili...
- New stem cell-rich collagen paste repairs defects ...
- Autologous Chondrocyte Implantation for Knee Carti...
- Consumer Updates > FDA Warns About Stem Cell Claims
Subscribe to
Comments [Atom]

2 Comments:
At March 29, 2012 at 8:58 AM ,
William Murrell Dubai Sports Doctor said...
In summary, these studies show for the first time that a population or sub-population of myogenic progenitors of the MyoD-lineage can make a significant cellular contribution to bone repair. In a fracture repair setting, this required disruption of the periosteum and trauma to the local tissues. In a defect repair setting, this required direct access to the muscle. These data suggest that the recruitment of MyoD-lineage cells can be highly dependent on the nature and location of the bone injury. Even in the surgical mouse models with the greatest myogenic progenitor contribution, approximately half of the cells originated from non-myogenic lineages. Thus cell lineages other than myogenic cells including vascular cells are also likely to have a major role in bone formation and repair.[23]
Apart from scientific clarification of the cellular contribution to bone repair in other orthopaedic models, future studies can aim to manipulate the surgical systems with the aim of maximizing MyoD-lineage cell access and mobilization to augment repair. Methods which optimize the contribution of secondary (non-periosteal) osteoprogenitors may be translatable to clinical practice and play a future role in improving the union rates of high energy and open fractures.
At March 29, 2012 at 1:03 PM ,
sagaworld said...
This comment has been removed by a blog administrator.
Post a Comment
Subscribe to Post Comments [Atom]
<< Home